Copyright Reports & Markets. All rights reserved.

Global Hidradenitis Suppurativa Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Hidradenitis Suppurativa Treatment by Type
    • 1.3.1 Overview: Global Hidradenitis Suppurativa Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Hidradenitis Suppurativa Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Medications
    • 1.3.4 Surgery
    • 1.3.5 Others
  • 1.4 Global Hidradenitis Suppurativa Treatment Market by Application
    • 1.4.1 Overview: Global Hidradenitis Suppurativa Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Others
  • 1.5 Global Hidradenitis Suppurativa Treatment Market Size & Forecast
  • 1.6 Global Hidradenitis Suppurativa Treatment Market Size and Forecast by Region
    • 1.6.1 Global Hidradenitis Suppurativa Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Hidradenitis Suppurativa Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America Hidradenitis Suppurativa Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Hidradenitis Suppurativa Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Hidradenitis Suppurativa Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America Hidradenitis Suppurativa Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.1.4 AbbVie Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.2.4 Merck Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merck Recent Developments and Future Plans
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.3.4 Pfizer Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Pfizer Recent Developments and Future Plans
  • 2.4 AstraZeneca
    • 2.4.1 AstraZeneca Details
    • 2.4.2 AstraZeneca Major Business
    • 2.4.3 AstraZeneca Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.4.4 AstraZeneca Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 AstraZeneca Recent Developments and Future Plans
  • 2.5 GlaxoSmithKline
    • 2.5.1 GlaxoSmithKline Details
    • 2.5.2 GlaxoSmithKline Major Business
    • 2.5.3 GlaxoSmithKline Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.5.4 GlaxoSmithKline Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.6 Perrigo
    • 2.6.1 Perrigo Details
    • 2.6.2 Perrigo Major Business
    • 2.6.3 Perrigo Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.6.4 Perrigo Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Perrigo Recent Developments and Future Plans
  • 2.7 Sun Pharma
    • 2.7.1 Sun Pharma Details
    • 2.7.2 Sun Pharma Major Business
    • 2.7.3 Sun Pharma Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.7.4 Sun Pharma Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Sun Pharma Recent Developments and Future Plans
  • 2.8 Almirall
    • 2.8.1 Almirall Details
    • 2.8.2 Almirall Major Business
    • 2.8.3 Almirall Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.8.4 Almirall Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Almirall Recent Developments and Future Plans
  • 2.9 Bausch Health
    • 2.9.1 Bausch Health Details
    • 2.9.2 Bausch Health Major Business
    • 2.9.3 Bausch Health Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.9.4 Bausch Health Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bausch Health Recent Developments and Future Plans
  • 2.10 Johnson & Johnson
    • 2.10.1 Johnson & Johnson Details
    • 2.10.2 Johnson & Johnson Major Business
    • 2.10.3 Johnson & Johnson Hidradenitis Suppurativa Treatment Product and Solutions
    • 2.10.4 Johnson & Johnson Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Johnson & Johnson Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Hidradenitis Suppurativa Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Hidradenitis Suppurativa Treatment by Company Revenue
    • 3.2.2 Top 3 Hidradenitis Suppurativa Treatment Players Market Share in 2023
    • 3.2.3 Top 6 Hidradenitis Suppurativa Treatment Players Market Share in 2023
  • 3.3 Hidradenitis Suppurativa Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Hidradenitis Suppurativa Treatment Market: Region Footprint
    • 3.3.2 Hidradenitis Suppurativa Treatment Market: Company Product Type Footprint
    • 3.3.3 Hidradenitis Suppurativa Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Hidradenitis Suppurativa Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Hidradenitis Suppurativa Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Hidradenitis Suppurativa Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Hidradenitis Suppurativa Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Hidradenitis Suppurativa Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America Hidradenitis Suppurativa Treatment Market Size by Application (2019-2030)
  • 6.3 North America Hidradenitis Suppurativa Treatment Market Size by Country
    • 6.3.1 North America Hidradenitis Suppurativa Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Hidradenitis Suppurativa Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe Hidradenitis Suppurativa Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe Hidradenitis Suppurativa Treatment Market Size by Country
    • 7.3.1 Europe Hidradenitis Suppurativa Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Hidradenitis Suppurativa Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Hidradenitis Suppurativa Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Hidradenitis Suppurativa Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Hidradenitis Suppurativa Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Hidradenitis Suppurativa Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America Hidradenitis Suppurativa Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America Hidradenitis Suppurativa Treatment Market Size by Country
    • 9.3.1 South America Hidradenitis Suppurativa Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Hidradenitis Suppurativa Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Hidradenitis Suppurativa Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Hidradenitis Suppurativa Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Hidradenitis Suppurativa Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Hidradenitis Suppurativa Treatment Market Drivers
  • 11.2 Hidradenitis Suppurativa Treatment Market Restraints
  • 11.3 Hidradenitis Suppurativa Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Hidradenitis Suppurativa Treatment Industry Chain
  • 12.2 Hidradenitis Suppurativa Treatment Upstream Analysis
  • 12.3 Hidradenitis Suppurativa Treatment Midstream Analysis
  • 12.4 Hidradenitis Suppurativa Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.
    The exact cause of hidradenitis suppurativa is unknown, but it occurs near hair follicles where there are sweat glands, usually around the groin, bottom, breasts and armpits.
    There"s no cure for HS, but treatments and lifestyle changes can bring some relief and cut down on flare-ups.
    According to our (Global Info Research) latest study, the global Hidradenitis Suppurativa Treatment market size was valued at US$ 692 million in 2023 and is forecast to a readjusted size of USD 914 million by 2030 with a CAGR of 4.1% during review period.
    The classification of Hidradenitis Suppurativa Treatment includes Medications, Surgery and others, and the proportion of Medications in 2019 is about 76%.
    Hidradenitis Suppurativa Treatment is widely used in Hospital, Clinical and other field. The most proportion of Hidradenitis Suppurativa Treatment is Hospital, and the proportion in 2019 is 53.53%.
    Europe is the largest consumption place with a consumption market share of 47.76% in 2019. Following Europe, Asia Pacific is the second largest consumption place with the consumption market share of 23.97%.
    Market competition is intense. AbbVie, Merck, Pfizer, AstraZeneca, GlaxoSmithKline, etc. are the leaders of the industry.
    This report is a detailed and comprehensive analysis for global Hidradenitis Suppurativa Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Hidradenitis Suppurativa Treatment market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Hidradenitis Suppurativa Treatment market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Hidradenitis Suppurativa Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Hidradenitis Suppurativa Treatment market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hidradenitis Suppurativa Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hidradenitis Suppurativa Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Merck, Pfizer, AstraZeneca, GlaxoSmithKline, Perrigo, Sun Pharma, Almirall, Bausch Health, Johnson & Johnson, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Hidradenitis Suppurativa Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Hidradenitis Suppurativa Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Medications
    Surgery
    Others
    Market segment by Application
    Hospitals
    Clinics
    Others
    Market segment by players, this report covers
    AbbVie
    Merck
    Pfizer
    AstraZeneca
    GlaxoSmithKline
    Perrigo
    Sun Pharma
    Almirall
    Bausch Health
    Johnson & Johnson
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Hidradenitis Suppurativa Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Hidradenitis Suppurativa Treatment, with revenue, gross margin, and global market share of Hidradenitis Suppurativa Treatment from 2019 to 2024.
    Chapter 3, the Hidradenitis Suppurativa Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hidradenitis Suppurativa Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Hidradenitis Suppurativa Treatment.
    Chapter 13, to describe Hidradenitis Suppurativa Treatment research findings and conclusion.

    Buy now